Drug-maker Lupin Ltd said on Wednesday that it has got an approval from the regulator United States Food and Drugs Administration (USFDA) to manufacture and sell its generic version of hypertension drug Amlodipine/Benazepril.
The commercial shipment of the product has commenced, a Lupin note said.
Lupin shares closed up by 1.12 per cent on the BSE, at Rs 450.25 on Wednesday.